{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-036423","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.124408+00:00","generated_at":"2026-06-28T13:37:19.361987+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin Q3 revenue $641.2M (-9% YoY), EPS $0.97 (-10%); cuts Q4 outlook","bullets":["Q3 revenue $641.2M, down 9% YoY; EPS $0.97 vs $1.08 in prior year.","Sales leaders down 15% to 58,565; customers down 9% to 1,395,271.","U.S. growth driven by Beauty Focus Collagen+ launch; Korea double-digit growth.","Q4 revenue guidance $645-675M (-10 to -14% YoY); EPS $0.90-1.00.","2021 full-year revenue guided $2.67-2.70B (+3-5%); EPS $3.93-4.03 (+8-11%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-036423","json":"https://secwatch.observer/filing/0001140361-21-036423.json","markdown":"https://secwatch.observer/filing/0001140361-21-036423.md","text":"https://secwatch.observer/filing/0001140361-21-036423.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121036423/0001140361-21-036423-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121036423/brhc10030354_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:37:19.361987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}